Viewing StudyNCT04391309



Ignite Creation Date: 2024-05-06 @ 2:42 PM
Last Modification Date: 2024-10-26 @ 1:35 PM
Study NCT ID: NCT04391309
Status: TERMINATED
Last Update Posted: 2023-06-26
First Post: 2020-05-14

Brief Title: COVID-19 and Anti-CD14 Treatment Trial
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Conditions & Keywords Data

Conditions:
Name
Coronavirus Disease 2019 COVID-19
Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2
Keywords:
Name View
hospitalized patients View
anti-CD14 anti-CD14 chimeric monoclonal antibody View
randomized double-blind placebo-controlled clinical trial View